BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ferenci P, Członkowska A, Merle U, Ferenc S, Gromadzka G, Yurdaydin C, Vogel W, Bruha R, Schmidt HT, Stremmel W. Late-onset Wilson's disease. Gastroenterology 2007;132:1294-8. [PMID: 17433323 DOI: 10.1053/j.gastro.2007.02.057] [Cited by in Crossref: 156] [Cited by in F6Publishing: 121] [Article Influence: 11.1] [Reference Citation Analysis]
Number Citing Articles
1 Kucinskas L, Jeroch J, Vitkauskiene A, Sakalauskas R, Petrenkiene V, Kucinskas V, Naginiene R, Schmidt H, Kupcinskas L. High frequency of the c.3207C>A (p.H1069Q) mutation in ATP7B gene of Lithuanian patients with hepatic presentation of Wilson’s disease. World J Gastroenterol 2008; 14(38): 5876-5879 [PMID: 18855987 DOI: 10.3748/wjg.14.5876] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
2 Lu CX, Qing Lin, Huang WQ, Tzeng CM. New mutations and polymorphisms of the ATP7B gene in sporadic Wilson disease. Eur J Med Genet. 2014;57:498-502. [PMID: 24878384 DOI: 10.1016/j.ejmg.2014.04.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
3 Hong SK, Yi NJ, Chang H, Ahn SW, Kim HS, Yoon KC, Kim H, Park SO, Jin US, Minn KW, Lee KW, Suh KS. The rate of hepatic artery complications is higher in pediatric liver transplant recipients with metabolic liver diseases than with biliary atresia. J Pediatr Surg 2018;53:1516-22. [PMID: 29861326 DOI: 10.1016/j.jpedsurg.2018.04.029] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Członkowska A, Litwin T, Chabik G. Wilson disease: neurologic features. Handb Clin Neurol 2017;142:101-19. [PMID: 28433096 DOI: 10.1016/B978-0-444-63625-6.00010-0] [Cited by in Crossref: 26] [Cited by in F6Publishing: 11] [Article Influence: 8.7] [Reference Citation Analysis]
5 Arai S, Kogiso T, Ogasawara Y, Sagawa T, Taniai M, Tokushige K. Long-term outcome of Wilson's disease complicated by liver disease. JGH Open 2021;5:793-800. [PMID: 34263074 DOI: 10.1002/jgh3.12589] [Reference Citation Analysis]
6 Ferenci P. Polymorphism of methylenetetrahydrofolate reductase as disease modifier - a déjà-vu in Wilson disease? J Hepatol 2011;55:753-5. [PMID: 21396415 DOI: 10.1016/j.jhep.2011.02.025] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
7 Dusek P, Litwin T, Czlonkowska A. Wilson disease and other neurodegenerations with metal accumulations. Neurol Clin. 2015;33:175-204. [PMID: 25432729 DOI: 10.1016/j.ncl.2014.09.006] [Cited by in Crossref: 48] [Cited by in F6Publishing: 40] [Article Influence: 8.0] [Reference Citation Analysis]
8 Ferenci P. Phenotype-genotype correlations in patients with Wilson’s disease. Ann N Y Acad Sci. 2014;1315:1-5. [PMID: 24517292 DOI: 10.1111/nyas.12340] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 6.1] [Reference Citation Analysis]
9 Tarnacka B, Szeszkowski W, Buettner J, Gołębiowski M, Gromadzka G, Członkowska A. Heterozygous carriers for Wilson’s disease—magnetic spectroscopy changes in the brain. Metab Brain Dis 2009;24:463-8. [DOI: 10.1007/s11011-009-9145-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
10 Paternostro R, Pfeiffenberger J, Ferenci P, Stättermayer AF, Stauber RE, Wrba F, Longerich T, Lackner K, Trauner M, Ferlitsch A, Reiberger T, Weiss KH. Non-invasive diagnosis of cirrhosis and long-term disease monitoring by transient elastography in patients with Wilson disease. Liver Int 2020;40:894-904. [PMID: 31898387 DOI: 10.1111/liv.14368] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
11 Groba SR, Guttmann S, Niemietz C, Bernick F, Sauer V, Hachmöller O, Karst U, Zischka H, Zibert A, Schmidt HH. Downregulation of hepatic multi-drug resistance protein 1 (MDR1) after copper exposure. Metallomics 2017;9:1279-87. [PMID: 28805879 DOI: 10.1039/c7mt00189d] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
12 Ferenci P. Diagnosis of Wilson disease. Handb Clin Neurol. 2017;142:171-180. [PMID: 28433100 DOI: 10.1016/b978-0-444-63625-6.00014-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
13 Guillaud O, Brunet AS, Mallet I, Dumortier J, Pelosse M, Heissat S, Rivet C, Lachaux A, Bost M. Relative exchangeable copper: A valuable tool for the diagnosis of Wilson disease. Liver Int 2018;38:350-7. [PMID: 28719006 DOI: 10.1111/liv.13520] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
14 Cleymaet S, Nagayoshi K, Gettings E, Faden J. A review and update on the diagnosis and treatment of neuropsychiatric Wilson disease. Expert Review of Neurotherapeutics 2019;19:1117-26. [DOI: 10.1080/14737175.2019.1645009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Pop TL, Grama A, Stefanescu AC, Willheim C, Ferenci P. Acute liver failure with hemolytic anemia in children with Wilson’s disease: Genotype-phenotype correlations? World J Hepatol 2021; 13(10): 1428-1438 [DOI: 10.4254/wjh.v13.i10.1428] [Reference Citation Analysis]
16 Lai CH, Tseng HF. Population-based epidemiologic study of Wilson's disease in Taiwan. Eur J Neurol 2010;17:830-3. [PMID: 20100230 DOI: 10.1111/j.1468-1331.2009.02946.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
17 Mihaylova V, Todorov T, Jelev H, Kotsev I, Angelova L, Kosseva O, Georgiev G, Ganeva R, Cherninkova S, Tankova L, Savov A, Tournev I. Neurological Symptoms, Genotype-Phenotype Correlations and Ethnic-specific Differences in Bulgarian Patients With Wilson Disease. The Neurologist 2012;18:184-9. [DOI: 10.1097/nrl.0b013e31825cf3b7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
18 Merle U, Weiss KH, Eisenbach C, Tuma S, Ferenci P, Stremmel W. Truncating mutations in the Wilson disease gene ATP7B are associated with very low serum ceruloplasmin oxidase activity and an early onset of Wilson disease. BMC Gastroenterol 2010;10:8. [PMID: 20082719 DOI: 10.1186/1471-230X-10-8] [Cited by in Crossref: 58] [Cited by in F6Publishing: 25] [Article Influence: 5.3] [Reference Citation Analysis]
19 Ferenci P. Whom and how to screen for Wilson disease. Expert Rev Gastroenterol Hepatol. 2014;8:513-520. [PMID: 24650289 DOI: 10.1586/17474124.2014.899898] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
20 Fang WY, Abuduxikuer K, Shi P, Qiu YL, Zhao J, Li YC, Zhang XY, Wang NL, Xie XB, Lu Y, Knisely AS, Wang JS. Pediatric Wilson disease presenting as acute liver failure: Prognostic indices. World J Clin Cases 2021; 9(14): 3273-3286 [PMID: 34002136 DOI: 10.12998/wjcc.v9.i14.3273] [Reference Citation Analysis]
21 Li H, Liu L, Li Y, He S, Liu Y, Li J, Tao R, Li W, Shang S. Familial screening of children with Wilson disease: Necessity of screening in previous generation and screening methods. Medicine (Baltimore) 2018;97:e11405. [PMID: 29979436 DOI: 10.1097/MD.0000000000011405] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Ryan A, Nevitt SJ, Tuohy O, Cook P. Biomarkers for diagnosis of Wilson's disease. Cochrane Database Syst Rev 2019;2019. [PMID: 31743430 DOI: 10.1002/14651858.CD012267.pub2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
23 Li LY, Zhu XQ, Tao WW, Yang WM, Chen HZ, Wang Y. Acute onset neurological symptoms in Wilson disease after traumatic, surgical or emotional events: A cross-sectional study. Medicine (Baltimore) 2019;98:e15917. [PMID: 31261498 DOI: 10.1097/MD.0000000000015917] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
24 Pfeiffenberger J, Kruse C, Mutch P, Harker A, Weiss KH. The steady state pharmacokinetics of trientine in Wilson disease patients. Eur J Clin Pharmacol 2018;74:731-6. [PMID: 29417175 DOI: 10.1007/s00228-018-2424-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
25 Honma Y, Harada M, Sato M, Katsuki Y, Hiura M, Shibata M, Narita R, Harada R, Abe S, Tabaru A, Tajiri N, Shimajiri S. Late diagnosed Wilson disease with hepatic and neurological manifestations: Late diagnosed Wilson disease. Hepatology Research 2011;41:270-6. [DOI: 10.1111/j.1872-034x.2010.00754.x] [Cited by in Crossref: 7] [Article Influence: 0.7] [Reference Citation Analysis]
26 Harada M. Pathogenesis and management of Wilson disease: Wilson disease. Hepatol Res 2014;44:395-402. [DOI: 10.1111/hepr.12301] [Cited by in Crossref: 32] [Cited by in F6Publishing: 20] [Article Influence: 4.6] [Reference Citation Analysis]
27 Poujois A, Woimant F. Challenges in the diagnosis of Wilson disease. Ann Transl Med 2019;7:S67. [PMID: 31179304 DOI: 10.21037/atm.2019.02.10] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
28 Žigrai M, Vyskočil M, Tóthová A, Vereš P, Bluska P, Valkovič P. Late-Onset Wilson's Disease. Front Med (Lausanne) 2020;7:26. [PMID: 32118011 DOI: 10.3389/fmed.2020.00026] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
29 Ferenci P, Roberts EA. Defining Wilson Disease Phenotypes: From the Patient to the Bench and Back Again. Gastroenterology 2012;142:692-6. [DOI: 10.1053/j.gastro.2012.02.035] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
30 Medici V, Czlonkowska A, Litwin T, Giulivi C. Diagnosis of Wilson Disease and Its Phenotypes by Using Artificial Intelligence. Biomolecules 2021;11:1243. [PMID: 34439909 DOI: 10.3390/biom11081243] [Reference Citation Analysis]
31 Dusek P, Litwin T, Członkowska A. Neurologic impairment in Wilson disease. Ann Transl Med 2019;7:S64. [PMID: 31179301 DOI: 10.21037/atm.2019.02.43] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 11.5] [Reference Citation Analysis]
32 Huster D. Wilson disease. Best Pract Res Clin Gastroenterol. 2010;24:531-539. [PMID: 20955957 DOI: 10.1016/j.bpg.2010.07.014] [Cited by in Crossref: 134] [Cited by in F6Publishing: 112] [Article Influence: 13.4] [Reference Citation Analysis]
33 Bandmann O, Weiss KH, Kaler SG. Wilson's disease and other neurological copper disorders. Lancet Neurol. 2015;14:103-113. [PMID: 25496901 DOI: 10.1016/s1474-4422(14)70190-5] [Cited by in Crossref: 381] [Cited by in F6Publishing: 115] [Article Influence: 63.5] [Reference Citation Analysis]
34 Guttmann S, Bernick F, Naorniakowska M, Michgehl U, Groba SR, Socha P, Zibert A, Schmidt HH. Functional Characterization of Novel ATP7B Variants for Diagnosis of Wilson Disease. Front Pediatr 2018;6:106. [PMID: 29761093 DOI: 10.3389/fped.2018.00106] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
35 Dzieżyc K, Karliński M, Litwin T, Członkowska A. Compliant treatment with anti-copper agents prevents clinically overt Wilson's disease in pre-symptomatic patients. Eur J Neurol 2014;21:332-7. [PMID: 24313946 DOI: 10.1111/ene.12320] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 5.0] [Reference Citation Analysis]
36 Sukezaki A, Chu PS, Shinoda M, Hibi T, Taniki N, Yoshida A, Kawaida M, Hori S, Morikawa R, Kurokouchi A, Wakino S, Kameyama K, Obara H, Kitagawa Y, Saito H, Kanai T, Nakamoto N. Late-onset acute liver failure due to Wilson's disease managed by plasmapheresis and hemodiafiltration successfully serving as a bridge for deceased donor liver transplantation: a case report and literature review. Clin J Gastroenterol 2020;13:1239-46. [PMID: 32643122 DOI: 10.1007/s12328-020-01175-8] [Reference Citation Analysis]
37 Tampaki M, Gatselis NK, Savvanis S, Koullias E, Saitis A, Gabeta S, Deutsch M, Manesis E, Dalekos GN, Koskinas J. Wilson disease: 30-year data on epidemiology, clinical presentation, treatment modalities and disease outcomes from two tertiary Greek centers. Eur J Gastroenterol Hepatol 2020;32:1545-52. [PMID: 32118851 DOI: 10.1097/MEG.0000000000001670] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
38 Gromadzka G, Karpińska A, Przybyłkowski A, Litwin T, Wierzchowska-Ciok A, Dzieżyc K, Chabik G, Członkowska A. Treatment with D-penicillamine or zinc sulphate affects copper metabolism and improves but not normalizes antioxidant capacity parameters in Wilson disease. Biometals 2014;27:207-15. [PMID: 24368744 DOI: 10.1007/s10534-013-9694-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
39 Zhou H, Fischer HP. [Hereditary hemochromatosis, alpha-1-antitrypsin deficiency and Wilson's disease. Pathogenesis, clinical findings and pathways to diagnosis]. Pathologe 2008;29:73-83. [PMID: 18210110 DOI: 10.1007/s00292-007-0954-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
40 Vierling JM, Sussman NL. Wilson Disease in Adults. Clinical and Translational Perspectives on WILSON DISEASE. Elsevier; 2019. pp. 165-77. [DOI: 10.1016/b978-0-12-810532-0.00016-1] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
41 Litwin T, Gromadzka G, Samochowiec J, Grzywacz A, Członkowski A, Członkowska A. Association of dopamine receptor gene polymorphisms with the clinical course of Wilson disease. JIMD Rep 2013;8:73-80. [PMID: 23430523 DOI: 10.1007/8904_2012_163] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
42 Hedera P. Wilson's disease: A master of disguise. Parkinsonism & Related Disorders 2019;59:140-5. [DOI: 10.1016/j.parkreldis.2019.02.016] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
43 Członkowska A, Litwin T, Dzieżyc K, Karliński M, Bring J, Bjartmar C. Characteristics of a newly diagnosed Polish cohort of patients with neurological manifestations of Wilson disease evaluated with the Unified Wilson's Disease Rating Scale. BMC Neurol 2018;18:34. [PMID: 29621974 DOI: 10.1186/s12883-018-1039-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
44 Kathawala M, Hirschfield GM. Insights into the management of Wilson's disease. Therap Adv Gastroenterol. 2017;10:889-905. [PMID: 29147139 DOI: 10.1177/1756283x17731520] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
45 Broniek‐kowalik K, Dzieżyc K, Litwin T, Członkowska A, Szaflik JP. Anterior segment optical coherence tomography ( ASOCT ) as a new method of detecting copper deposits forming the Kayser–Fleischer ring in patients with Wilson disease. Acta Ophthalmol 2019;97. [DOI: 10.1111/aos.14009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
46 Moores A, Fox S, Lang A, Hirschfield GM. Wilson disease: Canadian perspectives on presentation and outcomes from an adult ambulatory setting. Can J Gastroenterol 2012;26:333-9. [PMID: 22720274 DOI: 10.1155/2012/123431] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
47 Amano T, Matsubara T, Nishida T, Shimakoshi H, Shimoda A, Sugimoto A, Takahashi K, Mukai K, Yamamoto M, Hayashi S, Nakajima S, Fukui K, Inada M. Clinically diagnosed late-onset fulminant Wilson’s disease without cirrhosis: A case report. World J Gastroenterol 2018; 24(2): 290-296 [PMID: 29375214 DOI: 10.3748/wjg.v24.i2.290] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
48 Mak CM, Lam CW. Diagnosis of Wilson's disease: a comprehensive review. Crit Rev Clin Lab Sci 2008;45:263-90. [PMID: 18568852 DOI: 10.1080/10408360801991055] [Cited by in Crossref: 88] [Cited by in F6Publishing: 56] [Article Influence: 6.8] [Reference Citation Analysis]
49 Chung EJ, Kim EG, Kim SJ, Ji KH, Seo JH. Wilson's disease with cognitive impairment and without extrapyramidal signs: improvement of neuropsychological performance and reduction of MRI abnormalities with trientine treatment. Neurocase 2016;22:40-4. [PMID: 25988284 DOI: 10.1080/13554794.2015.1032977] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
50 Wilmarth PA, Short KK, Fiehn O, Lutsenko S, David LL, Burkhead JL. A systems approach implicates nuclear receptor targeting in the Atp7b(-/-) mouse model of Wilson's disease. Metallomics 2012;4:660-8. [PMID: 22565294 DOI: 10.1039/c2mt20017a] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
51 Boga S, Ala A, Schilsky ML. Hepatic features of Wilson disease. Handb Clin Neurol. 2017;142:91-99. [PMID: 28433114 DOI: 10.1016/b978-0-444-63625-6.00009-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
52 Twomey PJ, Viljoen A, Reynolds TM, Wierzbicki AS. Non-ceruloplasmin-bound copper in routine clinical practice in different laboratories. J Trace Elem Med Biol 2008;22:50-3. [PMID: 18319140 DOI: 10.1016/j.jtemb.2007.11.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
53 Arnon R, Annunziato R, Schilsky M, Miloh T, Willis A, Sturdevant M, Sakworawich A, Suchy F, Kerkar N. Liver transplantation for children with Wilson disease: comparison of outcomes between children and adults. Clin Transplant. 2011;25:E52-E60. [PMID: 20946468 DOI: 10.1111/j.1399-0012.2010.01327.x] [Cited by in Crossref: 59] [Cited by in F6Publishing: 44] [Article Influence: 5.4] [Reference Citation Analysis]
54 Gromadzka G, Wierzbicka D, Litwin T, Przybyłkowski A. Difference in iron metabolism may partly explain sex-related variability in the manifestation of Wilson's disease. J Trace Elem Med Biol 2020;62:126637. [PMID: 32937238 DOI: 10.1016/j.jtemb.2020.126637] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
55 Członkowska A, Rodo M, Gromadzka G. Late onset Wilson's disease: therapeutic implications. Mov Disord 2008;23:896-8. [PMID: 18311837 DOI: 10.1002/mds.21985] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 3.6] [Reference Citation Analysis]
56 Buksińska-Lisik M, Litwin T, Pasierski T, Członkowska A. Cardiac assessment in Wilson's disease patients based on electrocardiography and echocardiography examination. Arch Med Sci 2019;15:857-64. [PMID: 31360180 DOI: 10.5114/aoms.2017.69728] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
57 Chenbhanich J, Thongprayoon C, Atsawarungruangkit A, Phupitakphol T, Cheungpasitporn W. Osteoporosis and bone mineral density in patients with Wilson’s disease: a systematic review and meta-analysis. Osteoporos Int 2018;29:315-22. [DOI: 10.1007/s00198-017-4295-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
58 Weitzman E, Pappo O, Weiss P, Frydman M, Haviv-Yadid Y, Ben Ari Z. Late onset fulminant Wilson’s disease: A case report and review of the literature. World J Gastroenterol 2014; 20(46): 17656-17660 [PMID: 25516681 DOI: 10.3748/wjg.v20.i46.17656] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
59 Hedera P. Update on the clinical management of Wilson's disease. Appl Clin Genet 2017;10:9-19. [PMID: 28144156 DOI: 10.2147/TACG.S79121] [Cited by in Crossref: 38] [Cited by in F6Publishing: 15] [Article Influence: 9.5] [Reference Citation Analysis]
60 Gromadzka G, Kruszyńska M, Wierzbicka D, Litwin T, Dzieżyc K, Wierzchowska-Ciok A, Chabik G, Członkowska A. Gene variants encoding proteins involved in antioxidant defense system and the clinical expression of Wilson disease. Liver Int 2015;35:215-22. [PMID: 24517502 DOI: 10.1111/liv.12493] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
61 Członkowska A, Dzieżyc-Jaworska K, Kłysz B, Barbara RO, Litwin T. Difficulties in diagnosis and treatment of Wilson disease-a case series of five patients. Ann Transl Med 2019;7:S73. [PMID: 31179310 DOI: 10.21037/atm.2019.02.37] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Habek M, Gabelić T, Brinar VV, Pavliša G. Late-onset Wilson's disease presenting with general anxiety disorder. Acta Neuropsychiatr 2009;21:267-8. [DOI: 10.1111/j.1601-5215.2009.00408.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
63 Huster D, Kühne A, Bhattacharjee A, Raines L, Jantsch V, Noe J, Schirrmeister W, Sommerer I, Sabri O, Berr F. Diverse functional properties of Wilson disease ATP7B variants. Gastroenterology. 2012;142:947-956.e5. [PMID: 22240481 DOI: 10.1053/j.gastro.2011.12.048] [Cited by in Crossref: 91] [Cited by in F6Publishing: 68] [Article Influence: 10.1] [Reference Citation Analysis]
64 Höflich C, Brieger A, Zeuzem S, Plotz G. Investigation of the Wilson gene ATP7B transcriptional start site and the effect of core promoter alterations. Sci Rep 2021;11:7674. [PMID: 33828154 DOI: 10.1038/s41598-021-87000-9] [Reference Citation Analysis]
65 Schmidt HH. Role of genotyping in Wilson's disease. J Hepatol. 2009;50:449-452. [PMID: 19118916 DOI: 10.1016/j.jhep.2008.11.008] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
66 Hermann W. Classification and differential diagnosis of Wilson's disease. Ann Transl Med 2019;7:S63. [PMID: 31179300 DOI: 10.21037/atm.2019.02.07] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
67 Weiss KH, Schäfer M, Gotthardt DN, Angerer A, Mogler C, Schirmacher P, Schemmer P, Stremmel W, Sauer P. Outcome and development of symptoms after orthotopic liver transplantation for Wilson disease. Clin Transplant. 2013;27:914-922. [PMID: 24118554 DOI: 10.1111/ctr.12259] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 4.5] [Reference Citation Analysis]
68 Wu X, Leegwater PA, Fieten H. Canine Models for Copper Homeostasis Disorders. Int J Mol Sci 2016;17:196. [PMID: 26861285 DOI: 10.3390/ijms17020196] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 3.4] [Reference Citation Analysis]
69 Schaefer M, Gotthardt DN, Ganion N, Wohnsland S, Seessle J, Stremmel W, Pfeiffenberger J, Weiss KH. Wilson disease: Health-related quality of life and risk for depression. Clinics and Research in Hepatology and Gastroenterology 2016;40:349-56. [DOI: 10.1016/j.clinre.2015.09.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
70 Hermann W, Huster D. [Diagnostics of Wilson's disease]. Nervenarzt 2018;89:115-23. [PMID: 29159549 DOI: 10.1007/s00115-017-0452-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
71 Weiss KH, Thompson C, Dogterom P, Chiou YJ, Morley T, Jackson B, Amin N, Kamlin COF. Comparison of the Pharmacokinetic Profiles of Trientine Tetrahydrochloride and Trientine Dihydrochloride in Healthy Subjects. Eur J Drug Metab Pharmacokinet 2021;46:665-75. [PMID: 34357516 DOI: 10.1007/s13318-021-00704-1] [Reference Citation Analysis]
72 Devarbhavi H, Singh R, Adarsh CK, Sheth K, Kiran R, Patil M. Factors that predict mortality in children with Wilson disease associated acute liver failure and comparison of Wilson disease specific prognostic indices. J Gastroenterol Hepatol. 2014;29:380-386. [PMID: 24033813 DOI: 10.1111/jgh.12356] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
73 Ferenci P, Stremmel W, Członkowska A, Szalay F, Viveiros A, Stättermayer AF, Bruha R, Houwen R, Pop TL, Stauber R, Gschwantler M, Pfeiffenberger J, Yurdaydin C, Aigner E, Steindl‐munda P, Dienes H, Zoller H, Weiss KH. Age and Sex but Not ATP7B Genotype Effectively Influence the Clinical Phenotype of Wilson Disease. Hepatology 2019;69:1464-76. [DOI: 10.1002/hep.30280] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 23.5] [Reference Citation Analysis]
74 European Association for Study of Liver. EASL Clinical Practice Guidelines: Wilson's disease. J Hepatol. 2012;56:671-685. [PMID: 22340672 DOI: 10.1016/j.jhep.2011.11.007] [Cited by in Crossref: 553] [Cited by in F6Publishing: 388] [Article Influence: 61.4] [Reference Citation Analysis]
75 Patil M, Sheth KA, Krishnamurthy AC, Devarbhavi H. A review and current perspective on Wilson disease. J Clin Exp Hepatol. 2013;3:321-336. [PMID: 25755520 DOI: 10.1016/j.jceh.2013.06.002] [Cited by in Crossref: 48] [Cited by in F6Publishing: 34] [Article Influence: 6.0] [Reference Citation Analysis]
76 Kluska A, Kulecka M, Litwin T, Dziezyc K, Balabas A, Piatkowska M, Paziewska A, Dabrowska M, Mikula M, Kaminska D, Wiernicka A, Socha P, Czlonkowska A, Ostrowski J. Whole-exome sequencing identifies novel pathogenic variants across the ATP7B gene and some modifiers of Wilson's disease phenotype. Liver Int 2019;39:177-86. [DOI: 10.1111/liv.13967] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
77 Xiong Y, Zhou L, Wang H, Li H, Hu Y, Meng P, Zhang X, Huang P. Rapid laboratory diagnosis of Wilson’s disease: One-step simultaneous detection of exchangeable copper and ceruloplasmin in serum based on nanotechnology. Sensors and Actuators B: Chemical 2019;281:713-9. [DOI: 10.1016/j.snb.2018.11.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
78 Krawczyk M, Müllenbach R, Weber SN, Zimmer V, Lammert F. Genome-wide association studies and genetic risk assessment of liver diseases. Nat Rev Gastroenterol Hepatol. 2010;7:669-681. [PMID: 21045792 DOI: 10.1038/nrgastro.2010.170] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 4.2] [Reference Citation Analysis]
79 Seessle J, Gohdes A, Gotthardt DN, Pfeiffenberger J, Eckert N, Stremmel W, Reuner U, Weiss KH. Alterations of lipid metabolism in Wilson disease. Lipids Health Dis 2011;10:83. [PMID: 21595966 DOI: 10.1186/1476-511X-10-83] [Cited by in Crossref: 28] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
80 Lutsenko S. Atp7b-/- mice as a model for studies of Wilson's disease. Biochem Soc Trans 2008;36:1233-8. [PMID: 19021531 DOI: 10.1042/BST0361233] [Cited by in Crossref: 55] [Cited by in F6Publishing: 25] [Article Influence: 4.6] [Reference Citation Analysis]
81 Aggarwal A, Bhatt M. Wilson disease. Current Opinion in Neurology 2020;33:534-42. [DOI: 10.1097/wco.0000000000000837] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
82 Hedera P. Clinical management of Wilson disease. Ann Transl Med 2019;7:S66. [PMID: 31179303 DOI: 10.21037/atm.2019.03.18] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
83 Czaja AJ. Cryptogenic chronic hepatitis and its changing guise in adults. Dig Dis Sci. 2011;56:3421-3438. [PMID: 21647651 DOI: 10.1007/s10620-011-1769-9] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
84 Shah D. Wilson’s disease: Hepatic manifestations. Disease-a-Month 2014;60:465-74. [DOI: 10.1016/j.disamonth.2014.07.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
85 Weiss KH, Zischka H. Copper Directly Affects Intestinal Lipid Turnover. Gastroenterology 2018;154:15-7. [DOI: 10.1053/j.gastro.2017.11.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
86 Wiernicka A, Dądalski M, Jańczyk W, Kamińska D, Naorniakowska M, Hüsing-kabar A, Schmidt H, Socha P. Early Onset of Wilson Disease: Diagnostic Challenges. Journal of Pediatric Gastroenterology & Nutrition 2017;65:555-60. [DOI: 10.1097/mpg.0000000000001700] [Cited by in Crossref: 15] [Cited by in F6Publishing: 3] [Article Influence: 3.8] [Reference Citation Analysis]
87 Paranawithana NN, Martins AF, Clavijo Jordan V, Zhao P, Chirayil S, Meloni G, Sherry AD. A Responsive Magnetic Resonance Imaging Contrast Agent for Detection of Excess Copper(II) in the Liver In Vivo. J Am Chem Soc 2019;141:11009-18. [DOI: 10.1021/jacs.8b13493] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 6.5] [Reference Citation Analysis]
88 Walshe J. Wilson disease: a most unusual patient. QJM 2016;109:117-8. [DOI: 10.1093/qjmed/hcv142] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
89 Usta J, Abu Daya H, Halawi H, Al-Shareef I, El-Rifai O, Malli AH, Sharara AI, Habib RH, Barada K. Homozygosity for Non-H1069Q Missense Mutations in ATP7B Gene and Early Severe Liver Disease: Report of Two Families and a Meta-analysis. JIMD Rep. 2012;4:129-137. [PMID: 23430908 DOI: 10.1007/8904_2011_91] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
90 Barada K, El-Atrache M, El-Hajj II, Rida K, El-Hajjar J, Mahfoud Z, Usta J. Homozygous mutations in the conserved ATP hinge region of the Wilson disease gene: association with liver disease. J Clin Gastroenterol. 2010;44:432-439. [PMID: 20485189 DOI: 10.1097/mcg.0b013e3181ce5138] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
91 Pfeiffenberger J, Mogler C, Gotthardt DN, Schulze-Bergkamen H, Litwin T, Reuner U, Hefter H, Huster D, Schemmer P, Członkowska A, Schirmacher P, Stremmel W, Cassiman D, Weiss KH. Hepatobiliary malignancies in Wilson disease. Liver Int 2015;35:1615-22. [PMID: 25369181 DOI: 10.1111/liv.12727] [Cited by in Crossref: 49] [Cited by in F6Publishing: 34] [Article Influence: 7.0] [Reference Citation Analysis]
92 Lefkowitch JH. Hepatobiliary pathology. Curr Opin Gastroenterol 2008;24:269-77. [PMID: 18408454 DOI: 10.1097/MOG.0b013e3282f8e28f] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
93 Poujois A, Woimant F. Wilson's disease: A 2017 update. Clinics and Research in Hepatology and Gastroenterology 2018;42:512-20. [DOI: 10.1016/j.clinre.2018.03.007] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 10.7] [Reference Citation Analysis]
94 Gromadzka G, Rudnicka M, Chabik G, Przybyłkowski A, Członkowska A. Genetic variability in the methylenetetrahydrofolate reductase gene (MTHFR) affects clinical expression of Wilson's disease. J Hepatol 2011;55:913-9. [PMID: 21334398 DOI: 10.1016/j.jhep.2011.01.030] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
95 Chandhok G, Horvath J, Aggarwal A, Bhatt M, Zibert A, Schmidt HH. Functional analysis and drug response to zinc and D-penicillamine in stable ATP7B mutant hepatic cell lines. World J Gastroenterol 2016; 22(16): 4109-4119 [PMID: 27122662 DOI: 10.3748/wjg.v22.i16.4109] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
96 Carta MG, Sorbello O, Moro MF, Bhat KM, Demelia E, Serra A, Mura G, Sancassiani F, Piga M, Demelia L. Bipolar disorders and Wilson's disease. BMC Psychiatry 2012;12:52. [PMID: 22646910 DOI: 10.1186/1471-244X-12-52] [Cited by in Crossref: 43] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]
97 Collet C, Laplanche JL, Page J, Morel H, Woimant F, Poujois A. High genetic carrier frequency of Wilson's disease in France: discrepancies with clinical prevalence. BMC Med Genet 2018;19:143. [PMID: 30097039 DOI: 10.1186/s12881-018-0660-3] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 8.3] [Reference Citation Analysis]
98 Shribman S, Webb G, Taylor R, Warner TT, Duckworth A, Gimson A, Shenoy A, Griffiths W. Liver transplantation for late-onset presentations of acute liver failure in Wilson's disease: The UK experience over 2 decades. JHEP Rep 2020;2:100096. [PMID: 32322813 DOI: 10.1016/j.jhepr.2020.100096] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
99 Carta M, Mura G, Sorbello O, Farina G, Demelia L. Quality of Life and Psychiatric Symptoms in Wilson's Disease: the Relevance of Bipolar Disorders. Clin Pract Epidemiol Ment Health 2012;8:102-9. [PMID: 23049615 DOI: 10.2174/1745017901208010102] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
100 Mulligan C, Bronstein JM. Wilson Disease: An Overview and Approach to Management. Neurol Clin. 2020;38:417-432. [PMID: 32279718 DOI: 10.1016/j.ncl.2020.01.005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 15.0] [Reference Citation Analysis]
101 Bruguera M. [Liver diseases in the elderly]. Gastroenterol Hepatol. 2014;37:535-543. [PMID: 24951302 DOI: 10.1016/j.gastrohep.2014.04.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
102 Hermann W, Hennig C, Hoffmann J. [Misdiagnosis of Wilson's disease despite positive genetics]. Nervenarzt 2018;89:1408-10. [PMID: 29564470 DOI: 10.1007/s00115-018-0506-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
103 Yousefi M, Yousefi M, Gharravi AM. Late-onset Wilson disease in older patient without ophthalmological findings, a case report. Clin Case Rep 2019;7:1253-8. [PMID: 31183105 DOI: 10.1002/ccr3.2203] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
104 Trocello J, Chappuis P, El Balkhi S, Poupon J, Leyendecker A, Chaine P, Woimant F. Anomalies du métabolisme du cuivre chez l’adulte. La Revue de Médecine Interne 2010;31:750-6. [DOI: 10.1016/j.revmed.2009.11.012] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
105 Ljubić H, Kalauz M, Telarović S, Ferenci P, Ostojić R, Noli MC, Lepori MB, Hrstić I, Vuković J, Premužić M, Radić D, Ravić KG, Sertić J, Merkler A, Barišić AA, Loudianos G, Vucelić B. ATP7B Gene Mutations in Croatian Patients with Wilson Disease. Genetic Testing and Molecular Biomarkers 2016;20:112-7. [DOI: 10.1089/gtmb.2015.0213] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
106 Huster D. [Wilson disease]. Internist (Berl) 2018;59:159-74. [PMID: 29340742 DOI: 10.1007/s00108-017-0378-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
107 Gomes A, Dedoussis GV. Geographic distribution of ATP7B mutations in Wilson disease. Ann Hum Biol 2016;43:1-8. [PMID: 26207595 DOI: 10.3109/03014460.2015.1051492] [Cited by in Crossref: 38] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
108 Nelson PT, Head E, Schmitt FA, Davis PR, Neltner JH, Jicha GA, Abner EL, Smith CD, Van Eldik LJ, Kryscio RJ, Scheff SW. Alzheimer's disease is not "brain aging": neuropathological, genetic, and epidemiological human studies. Acta Neuropathol 2011;121:571-87. [PMID: 21516511 DOI: 10.1007/s00401-011-0826-y] [Cited by in Crossref: 180] [Cited by in F6Publishing: 167] [Article Influence: 18.0] [Reference Citation Analysis]
109 Weiss KH, Runz H, Noe B, Gotthardt DN, Merle U, Ferenci P, Stremmel W, Füllekrug J. Genetic analysis of BIRC4/XIAP as a putative modifier gene of Wilson disease. J Inherit Metab Dis 2010;33 Suppl 3:S233-40. [PMID: 20517649 DOI: 10.1007/s10545-010-9123-5] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 3.1] [Reference Citation Analysis]
110 Członkowska A, Gromadzka G, Chabik G. Monozygotic female twins discordant for phenotype of Wilson's disease. Mov Disord 2009;24:1066-9. [PMID: 19306278 DOI: 10.1002/mds.22474] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 4.8] [Reference Citation Analysis]
111 Weiss KH, Stremmel W. Evolving Perspectives in Wilson Disease: Diagnosis, Treatment and Monitoring. Curr Gastroenterol Rep 2012;14:1-7. [DOI: 10.1007/s11894-011-0227-3] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 3.7] [Reference Citation Analysis]
112 Gasca-Salas C, Alonso A, González-Redondo R, Obeso JA. Coexisting Parkinson's and Wilson's Disease: Chance or Connection? Can J Neurol Sci 2017;44:215-8. [PMID: 27831460 DOI: 10.1017/cjn.2016.327] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
113 Ferenci P, Litwin T, Seniow J, Czlonkowska A. Encephalopathy in Wilson disease: copper toxicity or liver failure? J Clin Exp Hepatol 2015;5:S88-95. [PMID: 26041965 DOI: 10.1016/j.jceh.2014.09.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
114 Pietrangelo A. Inherited metabolic disease of the liver. Curr Opin Gastroenterol 2009;25:209-14. [PMID: 19342951 DOI: 10.1097/MOG.0b013e328329e13d] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
115 Bruha R, Marecek Z, Pospisilova L, Nevsimalova S, Vitek L, Martasek P, Nevoral J, Petrtyl J, Urbanek P, Jiraskova A. Long-term follow-up of Wilson disease: natural history, treatment, mutations analysis and phenotypic correlation. Liver Int. 2011;31:83-91. [PMID: 20958917 DOI: 10.1111/j.1478-3231.2010.02354.x] [Cited by in Crossref: 68] [Cited by in F6Publishing: 63] [Article Influence: 6.2] [Reference Citation Analysis]
116 Woimant F, Djebrani-oussedik N, Collet C, Girardot N, Poujois A. The hidden face of Wilson's disease. Revue Neurologique 2018;174:589-96. [DOI: 10.1016/j.neurol.2018.08.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
117 Lo C, Bandmann O. Epidemiology and introduction to the clinical presentation of Wilson disease. Handb Clin Neurol 2017;142:7-17. [PMID: 28433111 DOI: 10.1016/B978-0-444-63625-6.00002-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
118 Xiong Y, Zhou L, Peng X, Li H, Wang H, He L, Huang P. A specific short peptide-assisted enhanced chemiluminescence resonance energy transfer (CRET) for label-free and ratiometric detection of copper ions in complex samples. Sensors and Actuators B: Chemical 2020;320:128411. [DOI: 10.1016/j.snb.2020.128411] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
119 Siaj R, Sauer V, Stöppeler S, Spiegel HU, Köhler G, Zibert A, Schmidt HH. Dietary copper triggers onset of fulminant hepatitis in the Long-Evans cinnamon rat model. World J Gastroenterol 2012; 18(39): 5542-5550 [PMID: 23112546 DOI: 10.3748/wjg.v18.i39.5542] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
120 Guindi M. Wilson disease. Semin Diagn Pathol. 2019;36:415-422. [PMID: 31421978 DOI: 10.1053/j.semdp.2019.07.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
121 Kumar SS, Kurian G, Eapen CE, Roberts EA. Genetics of Wilson's disease: a clinical perspective. Indian J Gastroenterol 2012;31:285-93. [PMID: 22941676 DOI: 10.1007/s12664-012-0237-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]